IRIS
PARODI, BRUNELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.146
Totale 10.146
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.146
Totale 10.146
Salva come PNG Salva come JPEG
Città #
Genova 7.914
Rapallo 1.265
Genoa 943
Bordighera 24
Totale 10.146
Salva come PNG Salva come JPEG
Nome #
A focus on mucoadhesive polymers and their application in buccal dosage forms 145
Green extraction from pomegranate marcs for the production of functional foods and cosmetics 141
Chitosan-clodronate nanoparticles loaded in poloxamer gel for intra-articular administration 137
Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-b-cyclodextrin in solution and in the solid state 136
Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino)ethyl 4-amino-benzoate, N4]-chlorideplatinum (II) monohydrochloride monohydrate 130
PREPARATION, CHARACTERIZATION AND IN VITRO ANTIVIRAL ACTIVITY EVALUATION OF FOSCARNET-CHITOSAN NANOPARTICLES 130
Microspheres containing carnosic acid for the treatment of basil fungal diseases 126
From pomegranate marcs to a potential bioactive ingredient: a recycling proposal for pomegranate squeezing marcs 123
Complex extemporaneous preparations: stability study of a formulation containing diethylpropion hydrochloride in hard capsules 122
An example of application of a mixture design with constraints to a pharmaceutical formulation 121
Development and characterization of a mucoadhesive sublingual formulation for pain control: extemporaneous oxycodone films in personalized therapy. 121
Study of retinoic acid polymorphism 118
Buccoadhesive oxycodone hydrochloride disks: plasma pharmacokinetics in healthy volunteers and clinical study 118
STABILITY INDICATING HPLC ASSAY FOR RETINOIC ACID IN HARD GELATINE CAPSULES CONTAINING LACTOSE AND AS BULK DRUG SUBSTANCE 116
An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose 115
Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice. 115
Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride 114
Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation 112
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 112
Median-based robust regression methods in prediction of drug stability 112
Preparation and evaluation of a chitosan salt–poloxamer 407 based matrix for buccal drug delivery 111
Somatostatin release from rat cerebral cortex synaptosomes 111
Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR. 109
Development, characterization and preliminary clinical evaluation of mucoadhesive vaginal gels containing chlorhexidine digluconate 106
Identification of degradation products of Ibuprofen arising from oxidative and thermal treatments 105
Stability study of hard gelatin capsules containing retinoic acid 104
Compound from Cupuliferae .15. Flavonoid Glycosides from Quercus-Canariensis Willd 102
A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraacetic acid useful for the localizationof radionuclides for diagnostic and therapeutic purposes (EP domanda) 102
A Method for the production of bioadhesive compact matrices (European Patent) 101
Phytotoxic activity of Salvia x jamensis 99
A new carrier for cisplatin: nanoparticles deriving from the interaction between N-trimethyl glycol chitosan and poly-L-glutamate 98
Blood and synovial levels of piroxicam and their effects on some metabolites of arachidonic acid 98
"A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid useful for the localization of radionuclides for diagnostic and therapeutic purpose" (PCT deposito) 98
Buccoadhesive polymeric films for oromucosal oxycodone delivery in acute pain control 95
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 95
Cisplatin Combined with the new Cisplatin-Procaine Complex DPR : In Vitro and In Vivo Studies 94
Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan 93
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex 93
A new conjugate of human albumin and p-SCN-Bn-DOTA for radioguided occult lesion localization in breast cancer (ROLL). 92
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (US Patent) 92
A method for the production of bioadhesive compact matrices (Japanese Patent) 91
Preparation and characterization of PLGA nanoparticles containing demethylfruticulin A from Salvia corrugata Vahl. (Lamiaceae) 91
Identificazione di nuovi prodotti di degradazione dell'ibuprofene. 90
Cisplatin delivery: a study on a cisplatin-hyaluronate complex and nanoparticles formed by its interaction with N-trimethyl chitosan 90
A Chitosan-Poloxamer 407 Matrix for Buccal Drug Delivery. 89
Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane 88
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED 87
Metodo di produzione di matrici compatte bioadesive impiegabili come tali o per il rilascio controllato di sostanze attive e matrici compatte così ottenute. 87
A Hydrophilic Matrix Generated by Direct Compression and Thermal Treatment: Application in Press-Coating 87
A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation 86
Characterisation and in vitro evaluation of biological activity of retinoic acid complexes with some bile salts 86
A New Hydrophilic Bioadhesive Matrix for Controlled Drug Release Generated in Direct Compression Tablets by Thermal Treatment: Mechanism Elucidation 84
Chitosan-Alginate Nanoparticles Containing Cisplatin Complexed With Alginate 83
Cytotoxicity and Cellular Accumulation of a New Cis-Diammineplatinum (II) Complex Containing Procaine in Murine L 1210 Cells Sensitive and Resistant to Cis-Diammine dicholoropatinum(II) 83
PROCEDE POUR LA FABRICATION DE MATRICES COMPACTES BIOADHESIVES QUI PEUVENT ETRE UTILISEES SOIT EN TANT QUE TELLES, SOIT POUR LA LIBERATION PROLONGEE DE SUBSTANCES ACTIVES ET MATRICES COMPACTES AINSI OBTENUES A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED (Canadian Patent) 83
Preparation of ellagic acid micro and nano formulations with amazingly increased water solubility by its entrapment in pectin or non-PAMAM dendrimers suitable for clinical applications 83
Flavonoid Glycosides from Quercus-Pubescens-Willd., Quercus-Cerris L. and Quercus-Ilex L.. 82
Preparation and evaluation of N-trimethyl chitosan/alginate nanoparticles containing cisplatin complexed with alginate 82
Modification of Drug Release from Tablets Produced By direct compression 81
Evaluation of a new matrix obtained by direct compression and thermal treatment in tablet press-coating 81
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (생체접착성 컴팩트 매트릭스의 제조방법) 81
Solubilization study of retinoic acid employing some bile salts 81
An alternative route of administration of oxycodone:pharmacokinetics and clinical development in cancer pain control 80
Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration. 80
Preliminary studies on the implementation of polymeric nanoparticles containing clodronate. 80
Preformulative study of liposomes containing retinoic acid 78
Nanoparticles Formed by Interaction of Poly-L-Lysine or Chitosan With Polycarboxylic Polymers Complexed with Cisplatin 78
Stabilization studies of chitosan/foscarnet nanoparticles by coating with Poloxamer 407 or glutaraldeyde cross-linking 76
Chemical and biological properties of a new Cis- diammineplatinum(II) complex containing para-aminobenzoic acid as amino ligand 75
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (China Patent) 75
A Method for the production of bioadhesive compact matrices (Russian Patent) 75
A novel nanoparticulate system based on a new cisplatin-hyaluronate complex and N-trimethyl chitosan 74
Applicazione del metodo di regressione robusta MBWR nella previsione di shelf life: stabilità di capsule contenenti acido retinoico. 73
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery Film polimerici mucoadesivi e sistemi a riserva per il rilascio transmucosale di farmaco 73
Pharmacokinetics of piroxicam in rheumatoid arthritis:relationship between plasma and synovial levels. 72
Herbal Mixtures with Claimed Slimming Activity - Determination by TLC and HPLC of Illegally Added Drugs 72
Preparation and Characterization of Brushite-Based Bone Cement 71
Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia 71
LONGROLL: a new human albumin conjugate for radioguided localization of non-palpable breast cancer lesion 71
Mucoadesive polymeric films and reservoir devices for transmucosal drug delivery. 70
Aspetti preliminari di uno studio preformulativo riguardante l'acido retinoico. 68
A Method for the production of bioadhesive compact matrices 68
SERUM, URINE AND PERITONEAL FLUID LEVELS OF 5-FU FOLLOWING IP ADMINISTRATION. 68
Cis-Diamminedichloroplatinum (II) - Procaine Pharmacokinetic Interaction in Mice Bearing P388 Leukemia 66
Optimization of a parenteral thermoresponsive formulation based on metformin hydrochloride 66
A water-soluble 1,2-diaminocyclohexaneplatinum(II) complex containing procaine hydrochloride: synthesis and antiproliferative activity in vitro 65
Gel di fibrina contenenti un complesso cisplatino-ialuronato o nanoparticelle polimeriche da esso derivate per la terapia tumorale locale 65
RESORBABLE BRUSHITE BONE CEMENT WITH CONTROLLED DRUG-RELEASING CAPABILITIES 65
Preparation and characterization of foscarnet/chitosan nanoparticles 64
FUNCTIONAL INTERACTIONS BETWEEN ALL TRANS RETINOIC ACID AND BILE SALTS ON CELL PROLIFERATION. 64
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery 63
Rivestimento con film polimerici di forme di dosaggio buccoadesive 62
Formulazione bioadesiva per somministrazione boccale di Ossicodone cloridrato 61
Amazing increase of Ellagic Acid solubility by its entrapping into not PAMAM-structured biocompatible dendrimer scaffolds 60
Piroxicam loaded spray dried microspheres as carrier in controlled drug delivery. 60
Valutazione preliminare dell'applicabilità del metodo statistico di regressione robusta LMS alla previsione di stabilità 59
Valutazione dell'uso dei compatti di mucina come substrato negli screening preformulativi di mucoadesività 59
An experience in mucoadhesive drug delivery 59
Complessazione dell’acido retinoico mediante sali di acidi biliari: caratterizzazione chimico-fisica e valutazione dell’efficacia antiproliferativa su colture cellulari 58
Development of gel formulations for localized release of metformin 58
Totale 8.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.475
article - articoli 13.269
book - libri 0
conference - conferenze 9.588
curatela - curatele 0
other - altro 0
patent - brevetti 2.618
selected - selezionate 0
volume - volumi 0
Totale 50.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019240 0 0 0 0 0 0 0 0 0 0 133 107
2019/20202.644 109 54 154 115 192 283 395 99 184 554 394 111
2020/2021468 29 27 29 31 18 51 16 36 60 56 62 53
2021/20221.460 23 133 95 196 41 75 91 363 54 129 66 194
2022/20231.534 160 104 14 204 221 287 4 114 280 10 120 16
2023/2024700 37 101 19 107 51 251 43 31 39 21 0 0
Totale 10.299